Authentidate Holding (ADAT) 3.9200 $ADAT
Authentidate Announces AEON's audited results for the year ended December 31, 2015
GlobeNewswire - Mon Apr 25, 3:01PM CDT
2015 Revenue of $34.85 Million
UPDATE -- OTCQX and OTCQB Companies to Present at 2016 Roth Conference
PR Newswire - Mon Mar 14, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
VRAY: 4.05 (+0.01), CDXC: 3.94 (+0.13)
OTCQX And OTCQB Companies To Present At 2016 ROTH Conference
PR Newswire - Thu Mar 10, 6:00AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
VRAY: 4.05 (+0.01), CDXC: 3.94 (+0.13)
Tom Leahey, Appointed Interim Chief Financial Officer of Authentidate
GlobeNewswire - Fri Mar 04, 8:00AM CST
Authentidate Holding Corp. (OTCQB:ADAT), one of the fastest growing clinical labs in North America through its wholly owned subsidiary Aeon Clinical Laboratories, and a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced it has appointed Tom Leahey as interim Chief Financial Officer. Mr. Leahey, a Principal and Practice Leader of the Strategic Growth Advisory Practice at Atlanta-based accounting firm Windham Brannon, succeeds Bill Marshall, who resigned from Authentidate effective March 1, 2016, in accordance with the terms of the merger with Aeon Clinical Laboratories, previously reported on January 27, 2016.
Authentidate to Present at 28th Annual Roth Conference
GlobeNewswire - Thu Mar 03, 8:00AM CST
Authentidate Holding Corp. (OTCQB:ADAT), one of the fastest growing clinical labs in the country through its wholly owned subsidiary AEON Clinical Laboratories, and a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced that management will present at the 28th Annual ROTH Conference at the Ritz-Carlton, Laguna Niguel, CA at 9:00 a.m. PT on Wednesday, March 16, 2016 in Salon 2 - Blue. A link to an audio webcast of the event will be available on the Investor Relations section of the Company's website.
Authentidate Announces AEON's Nine-Month 2015 Financial Results: $21.6 Million in Revenue, $6.8 Million Net Income and $6.9 Million in Cash
GlobeNewswire - Tue Feb 02, 7:00AM CST
Company to Discuss Merger With AEON, Introduce AEON Business and New Senior Management, in Conference Call today at 12 p.m. ET
Authentidate to Discuss Merger With AEON, Introduce New Senior Management, in Conference Call on Tuesday, February 2, 2016
GlobeNewswire - Fri Jan 29, 1:29PM CST
Authentidate Holding Corp. (Nasdaq:ADAT) today announced that it plans to host a conference call on Tuesday, February 2, 2016, at 12:00 p.m. ET, to discuss the company's recently completed merger transaction whereby privately-held AEON has merged with a wholly-owned subsidiary of Authentidate, creating a company focused on delivering innovative solutions that achieve technology best practices in medicine and raise the standard of healthcare. The call will be hosted by Richard Hersperger, the Company's new Chief Executive Officer, and Mr. Hersperger will take questions from investors.
Authentidate and AEON Clinical Laboratories Complete Merger to Form Innovative Healthcare Technology Company
GlobeNewswire - Thu Jan 28, 7:30AM CST
Authentidate Common Stock to Commence Trading on the OTCQB Market
Authentidate and AEON Clinical Laboratories Execute Amendment to Merger Agreement and Schedule Closing
GlobeNewswire - Wed Jan 27, 8:00AM CST
Authentidate Holding Corp. (NASDAQ:ADAT) and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories, today announced that they have entered into an amendment to their agreement and plan of merger whereby privately-held AEON will merge with a wholly-owned subsidiary of Authentidate and become a wholly owned subsidiary of Authentidate.
Authentidate Holding authorises reverse common stock split
M2 - Mon Jan 25, 7:45AM CST
Telehealth products company Authentidate Holding (NasdaqCM:ADAT) said on Friday that its stockholders have approved a one-for-nine reverse split of its common stock at a special meeting held on 20 January 2016.
Authentidate Holding Corp. Announces Reverse Stock Split
GlobeNewswire - Fri Jan 22, 4:36PM CST
Common stock will begin trading on a split-adjusted basis on January 25, 2016
Authentidate Announces First Quarter Financial Results
GlobeNewswire - Fri Nov 13, 3:05PM CST
Authentidate Holding Corp. (Nasdaq:ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced financial results for the first quarter ended September 30, 2015. In addition, the company announced that efforts related to its business combination with AEON Clinical Laboratories continue to progress.
Authentidate Announces Fourth Quarter and Full Year Financial Results
GlobeNewswire - Tue Oct 13, 3:02PM CDT
Authentidate Holding Corp. (Nasdaq:ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced financial results for the fourth quarter and full-year periods ended June 30, 2015. In addition, the company announced that due diligence related to its combination with AEON Clinical Laboratories continues to progress, and cross selling between AEON's clinical solutions and Authentidate's telehealth delivery solutions is continuing.
Authentidate Announces Receipt of Favorable NASDAQ Listing Determination
GlobeNewswire - Mon Sep 21, 8:00AM CDT
Authentidate Holding Corp. (Nasdaq:ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced its receipt of a positive decision from the NASDAQ Hearings Panel, which has granted the company's request for the continued listing of its common stock on NASDAQ, subject to the conditions that the company complete the proposed business combination with Peachstate Health Management, LLC (d/b/a AEON Clinical Laboratories) and that the NASDAQ Listing Qualifications Staff approve the combined company's application for initial listing on NASDAQ on or before January 25, 2016.
AEON and Authentidate Launch Cancer Genetic Testing With Telehealth-Based Genetic Counseling
GlobeNewswire - Thu Sep 17, 7:00AM CDT
Authentidate Holding Corp. (Nasdaq:ADAT), has partnered with AEON Clinical Laboratories to nationally launch Cancer Detect Profile(R), a 38-gene cancer genetic test coupled with telehealth-based genetic counseling for the prescribing physicians. The test is designed to identify patients with increased risk of colorectal, breast, pancreatic, ovarian, gastric, melanoma, stomach and other cancers. The test is now available for use by AEON's base of more than 6,000 physicians who annually treat more than one million patients nationwide.
AEON Clinical Laboratory & Authentidate partnership to provide mental health services to patients of Houston Clinics
M2 - Mon Sep 07, 5:16AM CDT
Telehealth products company Authentidate Holding (NasdaqCM:ADAT) reported on Friday that it has implemented the first cross-sold application of its leading telehealth solutions with AEON Clinical Laboratory's leading clinical solutions
AEON Clinical Laboratory Partners With Authentidate's HIPAA-Compliant Telehealth Platform for Houston Clinics
GlobeNewswire - Fri Sep 04, 8:47AM CDT
Authentidate Holding Corp. (Nasdaq:ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced the first cross-sold application of Authentidate's leading telehealth solutions and AEON Clinical Laboratory's leading clinical solutions. As announced on August 25, 2015, Authentidate and AEON Clinical Laboratories have entered into a non-binding letter of intent to combine.
Advanced Remote Patient Monitoring Systems Market Report, 2015 Edition
M2 - Fri Jul 24, 8:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3x94gc/advanced_remote) has announced the addition of the "Advanced Remote Patient Monitoring Systems, 8th Edition" report to their offering. New patient monitoring systems are emerging in response to the increased healthcare needs of an aging population, new wireless technologies, better video and monitoring technologies, decreasing healthcare resources, an emphasis on reducing hospital days, and proven cost-effectiveness. Advanced Remote Patient Monitoring Systems, in its eighth edition, is a comprehensive study on the patient monitoring industry, including patient monitoring equipment and devices which have advanced features. The report specifically focuses on technologically advanced (including wireless and remote) patient monitors; monitors with patient data processing applications; and monitors which are capable of data transfer to an EMR system-including equipment and peripherals which coordinate the flow of data to hospital electronic medical record systems. This report provides complete market sizes and forecasts for the important segments of the advanced monitoring market: - Blood Management and Function Monitors (Glucose Monitors, Blood Pressure Monitors, PT/INR Monitors, Other Monitors) - Cardiac Event and Function Monitors (Cardiac Rhythm/Event Monitors, EKG/ECG, Fetal Heart, Other Monitors) - Neurological Event Monitors (EEG, Other Equipment) - Respiratory Function Monitors (Anesthesia Monitors, Capnographs, Pulse Oximeters, Sleep Monitors, Spirometers) - Other Advanced Monitors Key Topics Covered: One: Executive Summary Two: Introduction Three: Advanced Patient Monitoring Products And Technologies Four: Competitor Trends And Market Share Analysis Five: Market Trends & Indicators Six: Global Market Size And Forecast Seven: Global Markets: Regional Analysis Regional Market Summary Eight: Corporate Profiles - Abbott - Aerotel Medical Systems - Alere, Inc. - AMD Global Telemedicine - American TeleCare - AuthentiDate Holding Corporation - B.Braun Melsungen AG - Baxter International - BioTelemetry, Inc. - Biotronik - Bosch Healthcare - Boston Scientific - Cardiocom, LLC. - Carematix, Inc. - Compumedics, Ltd. - CONMED Corporation - C.R. Bard, Inc. - Criticare Systems, Inc. - Dexcom, Inc. - Draeger Medical - Fukuda Denshi Co. - GE Healthcare - Getinge Group - GlobalMed Group - Hoana Medical, Inc. - Honeywell HomMed - Infinium Medical, Inc. - Insulet - InTechnology plc - Intel Corporation - InTouch Health - Johnson & Johnson - LifeWatch Technologies - Masimo Corporation - Medtronic For more information visit http://www.researchandmarkets.com/research/3x...ced_remote
MASI: 52.33 (+0.34), BCR: 239.00 (+1.20), MDT: 88.36 (+0.87), HON: 118.84 (+2.73), MDSY: 1.55 (unch), ALR: 39.78 (-0.36), INTC: 34.00 (+0.80), BSX: 23.90 (+0.24), CMD: 112.31 (+5.20), JNJ: 122.85 (+0.34), BAX: 46.65 (+0.53), BEAT: 16.54 (+0.17), CNMD: 48.68 (+0.94)
Renal Ventures Management, LLC Signs Agreement with Authentidate for Remote Patient Monitoring
BusinessWire - Tue Jul 07, 10:00AM CDT
Renal Ventures Management, LLC (RVM), a leading provider of dialysis services for patients suffering from chronic kidney failure, recently selected Telehealth Solutions from Authentidate Holding Corp. (Nasdaq:ADAT) for remote monitoring of select RVM dialysis patients. The rollout is expected to begin in the third quarter of 2015.
Renal Ventures Management Signs Agreement With Authentidate for Remote Patient Monitoring
GlobeNewswire - Tue Jul 07, 8:00AM CDT
Authentidate Holding Corp. (Nasdaq:ADAT), a provider of web-based revenue cycle management applications and telehealth products and services for healthcare organizations, announced today that Renal Ventures Management, LLC (RVM), a leading provider of dialysis services for patients suffering from chronic kidney failure, selected Authentidate's telehealth solution for the remote monitoring of some of the dialysis patients who have kidney failure. The roll out is expected to begin in the third quarter of 2015.
Authentidate Announces AEON's audited results for the year ended December 31, 2015
GlobeNewswire - Mon Apr 25, 3:01PM CDT
2015 Revenue of $34.85 Million
UPDATE -- OTCQX and OTCQB Companies to Present at 2016 Roth Conference
PR Newswire - Mon Mar 14, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
VRAY: 4.05 (+0.01), CDXC: 3.94 (+0.13)
OTCQX And OTCQB Companies To Present At 2016 ROTH Conference
PR Newswire - Thu Mar 10, 6:00AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the lineup of OTCQX® Best and OTCQB® Venture Market companies presenting at the 28th Annual ROTH Conference, taking place March 13-16 at the Ritz-Carlton in Dana Point, CA. The ROTH Conference, hosted by ROTH Capital Partners, LLC, is one of the largest small-cap investment conferences in the U.S., featuring presentations by senior executives from hundreds of public and private companies in a wide variety of sectors.
VRAY: 4.05 (+0.01), CDXC: 3.94 (+0.13)
Tom Leahey, Appointed Interim Chief Financial Officer of Authentidate
GlobeNewswire - Fri Mar 04, 8:00AM CST
Authentidate Holding Corp. (OTCQB:ADAT), one of the fastest growing clinical labs in North America through its wholly owned subsidiary Aeon Clinical Laboratories, and a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced it has appointed Tom Leahey as interim Chief Financial Officer. Mr. Leahey, a Principal and Practice Leader of the Strategic Growth Advisory Practice at Atlanta-based accounting firm Windham Brannon, succeeds Bill Marshall, who resigned from Authentidate effective March 1, 2016, in accordance with the terms of the merger with Aeon Clinical Laboratories, previously reported on January 27, 2016.
Authentidate to Present at 28th Annual Roth Conference
GlobeNewswire - Thu Mar 03, 8:00AM CST
Authentidate Holding Corp. (OTCQB:ADAT), one of the fastest growing clinical labs in the country through its wholly owned subsidiary AEON Clinical Laboratories, and a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced that management will present at the 28th Annual ROTH Conference at the Ritz-Carlton, Laguna Niguel, CA at 9:00 a.m. PT on Wednesday, March 16, 2016 in Salon 2 - Blue. A link to an audio webcast of the event will be available on the Investor Relations section of the Company's website.
Authentidate Announces AEON's Nine-Month 2015 Financial Results: $21.6 Million in Revenue, $6.8 Million Net Income and $6.9 Million in Cash
GlobeNewswire - Tue Feb 02, 7:00AM CST
Company to Discuss Merger With AEON, Introduce AEON Business and New Senior Management, in Conference Call today at 12 p.m. ET
Authentidate to Discuss Merger With AEON, Introduce New Senior Management, in Conference Call on Tuesday, February 2, 2016
GlobeNewswire - Fri Jan 29, 1:29PM CST
Authentidate Holding Corp. (Nasdaq:ADAT) today announced that it plans to host a conference call on Tuesday, February 2, 2016, at 12:00 p.m. ET, to discuss the company's recently completed merger transaction whereby privately-held AEON has merged with a wholly-owned subsidiary of Authentidate, creating a company focused on delivering innovative solutions that achieve technology best practices in medicine and raise the standard of healthcare. The call will be hosted by Richard Hersperger, the Company's new Chief Executive Officer, and Mr. Hersperger will take questions from investors.
Authentidate and AEON Clinical Laboratories Complete Merger to Form Innovative Healthcare Technology Company
GlobeNewswire - Thu Jan 28, 7:30AM CST
Authentidate Common Stock to Commence Trading on the OTCQB Market
Authentidate and AEON Clinical Laboratories Execute Amendment to Merger Agreement and Schedule Closing
GlobeNewswire - Wed Jan 27, 8:00AM CST
Authentidate Holding Corp. (NASDAQ:ADAT) and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories, today announced that they have entered into an amendment to their agreement and plan of merger whereby privately-held AEON will merge with a wholly-owned subsidiary of Authentidate and become a wholly owned subsidiary of Authentidate.
Authentidate Holding authorises reverse common stock split
M2 - Mon Jan 25, 7:45AM CST
Telehealth products company Authentidate Holding (NasdaqCM:ADAT) said on Friday that its stockholders have approved a one-for-nine reverse split of its common stock at a special meeting held on 20 January 2016.
Authentidate Holding Corp. Announces Reverse Stock Split
GlobeNewswire - Fri Jan 22, 4:36PM CST
Common stock will begin trading on a split-adjusted basis on January 25, 2016
Authentidate Announces First Quarter Financial Results
GlobeNewswire - Fri Nov 13, 3:05PM CST
Authentidate Holding Corp. (Nasdaq:ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced financial results for the first quarter ended September 30, 2015. In addition, the company announced that efforts related to its business combination with AEON Clinical Laboratories continue to progress.
Authentidate Announces Fourth Quarter and Full Year Financial Results
GlobeNewswire - Tue Oct 13, 3:02PM CDT
Authentidate Holding Corp. (Nasdaq:ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced financial results for the fourth quarter and full-year periods ended June 30, 2015. In addition, the company announced that due diligence related to its combination with AEON Clinical Laboratories continues to progress, and cross selling between AEON's clinical solutions and Authentidate's telehealth delivery solutions is continuing.
Authentidate Announces Receipt of Favorable NASDAQ Listing Determination
GlobeNewswire - Mon Sep 21, 8:00AM CDT
Authentidate Holding Corp. (Nasdaq:ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced its receipt of a positive decision from the NASDAQ Hearings Panel, which has granted the company's request for the continued listing of its common stock on NASDAQ, subject to the conditions that the company complete the proposed business combination with Peachstate Health Management, LLC (d/b/a AEON Clinical Laboratories) and that the NASDAQ Listing Qualifications Staff approve the combined company's application for initial listing on NASDAQ on or before January 25, 2016.
AEON and Authentidate Launch Cancer Genetic Testing With Telehealth-Based Genetic Counseling
GlobeNewswire - Thu Sep 17, 7:00AM CDT
Authentidate Holding Corp. (Nasdaq:ADAT), has partnered with AEON Clinical Laboratories to nationally launch Cancer Detect Profile(R), a 38-gene cancer genetic test coupled with telehealth-based genetic counseling for the prescribing physicians. The test is designed to identify patients with increased risk of colorectal, breast, pancreatic, ovarian, gastric, melanoma, stomach and other cancers. The test is now available for use by AEON's base of more than 6,000 physicians who annually treat more than one million patients nationwide.
AEON Clinical Laboratory & Authentidate partnership to provide mental health services to patients of Houston Clinics
M2 - Mon Sep 07, 5:16AM CDT
Telehealth products company Authentidate Holding (NasdaqCM:ADAT) reported on Friday that it has implemented the first cross-sold application of its leading telehealth solutions with AEON Clinical Laboratory's leading clinical solutions
AEON Clinical Laboratory Partners With Authentidate's HIPAA-Compliant Telehealth Platform for Houston Clinics
GlobeNewswire - Fri Sep 04, 8:47AM CDT
Authentidate Holding Corp. (Nasdaq:ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced the first cross-sold application of Authentidate's leading telehealth solutions and AEON Clinical Laboratory's leading clinical solutions. As announced on August 25, 2015, Authentidate and AEON Clinical Laboratories have entered into a non-binding letter of intent to combine.
Advanced Remote Patient Monitoring Systems Market Report, 2015 Edition
M2 - Fri Jul 24, 8:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3x94gc/advanced_remote) has announced the addition of the "Advanced Remote Patient Monitoring Systems, 8th Edition" report to their offering. New patient monitoring systems are emerging in response to the increased healthcare needs of an aging population, new wireless technologies, better video and monitoring technologies, decreasing healthcare resources, an emphasis on reducing hospital days, and proven cost-effectiveness. Advanced Remote Patient Monitoring Systems, in its eighth edition, is a comprehensive study on the patient monitoring industry, including patient monitoring equipment and devices which have advanced features. The report specifically focuses on technologically advanced (including wireless and remote) patient monitors; monitors with patient data processing applications; and monitors which are capable of data transfer to an EMR system-including equipment and peripherals which coordinate the flow of data to hospital electronic medical record systems. This report provides complete market sizes and forecasts for the important segments of the advanced monitoring market: - Blood Management and Function Monitors (Glucose Monitors, Blood Pressure Monitors, PT/INR Monitors, Other Monitors) - Cardiac Event and Function Monitors (Cardiac Rhythm/Event Monitors, EKG/ECG, Fetal Heart, Other Monitors) - Neurological Event Monitors (EEG, Other Equipment) - Respiratory Function Monitors (Anesthesia Monitors, Capnographs, Pulse Oximeters, Sleep Monitors, Spirometers) - Other Advanced Monitors Key Topics Covered: One: Executive Summary Two: Introduction Three: Advanced Patient Monitoring Products And Technologies Four: Competitor Trends And Market Share Analysis Five: Market Trends & Indicators Six: Global Market Size And Forecast Seven: Global Markets: Regional Analysis Regional Market Summary Eight: Corporate Profiles - Abbott - Aerotel Medical Systems - Alere, Inc. - AMD Global Telemedicine - American TeleCare - AuthentiDate Holding Corporation - B.Braun Melsungen AG - Baxter International - BioTelemetry, Inc. - Biotronik - Bosch Healthcare - Boston Scientific - Cardiocom, LLC. - Carematix, Inc. - Compumedics, Ltd. - CONMED Corporation - C.R. Bard, Inc. - Criticare Systems, Inc. - Dexcom, Inc. - Draeger Medical - Fukuda Denshi Co. - GE Healthcare - Getinge Group - GlobalMed Group - Hoana Medical, Inc. - Honeywell HomMed - Infinium Medical, Inc. - Insulet - InTechnology plc - Intel Corporation - InTouch Health - Johnson & Johnson - LifeWatch Technologies - Masimo Corporation - Medtronic For more information visit http://www.researchandmarkets.com/research/3x...ced_remote
MASI: 52.33 (+0.34), BCR: 239.00 (+1.20), MDT: 88.36 (+0.87), HON: 118.84 (+2.73), MDSY: 1.55 (unch), ALR: 39.78 (-0.36), INTC: 34.00 (+0.80), BSX: 23.90 (+0.24), CMD: 112.31 (+5.20), JNJ: 122.85 (+0.34), BAX: 46.65 (+0.53), BEAT: 16.54 (+0.17), CNMD: 48.68 (+0.94)
Renal Ventures Management, LLC Signs Agreement with Authentidate for Remote Patient Monitoring
BusinessWire - Tue Jul 07, 10:00AM CDT
Renal Ventures Management, LLC (RVM), a leading provider of dialysis services for patients suffering from chronic kidney failure, recently selected Telehealth Solutions from Authentidate Holding Corp. (Nasdaq:ADAT) for remote monitoring of select RVM dialysis patients. The rollout is expected to begin in the third quarter of 2015.
Renal Ventures Management Signs Agreement With Authentidate for Remote Patient Monitoring
GlobeNewswire - Tue Jul 07, 8:00AM CDT
Authentidate Holding Corp. (Nasdaq:ADAT), a provider of web-based revenue cycle management applications and telehealth products and services for healthcare organizations, announced today that Renal Ventures Management, LLC (RVM), a leading provider of dialysis services for patients suffering from chronic kidney failure, selected Authentidate's telehealth solution for the remote monitoring of some of the dialysis patients who have kidney failure. The roll out is expected to begin in the third quarter of 2015.
